Latest news
Novo Nordisk (NVO) Trial Setback Hits Sentiment, Is The Stock Still Cheap? - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTUpdated: GSK reveals three-year blueprint to cut costs and propel R&D - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMTJapan: home-grown ‘salmon’ push hit by 84% losses at Hokkaido trial - Salmon BusinessSalmon Business · Mon, 27 Jul 2026 08:08:11 GMT